Considerations for management of patients with diabetic macular edema: optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaboration

2.50
Hdl Handle:
http://hdl.handle.net/11287/620216
Title:
Considerations for management of patients with diabetic macular edema: optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaboration
Authors:
Strain, David; Cos, X.; Prünte, C.
Abstract:
Diabetes is a growing worldwide epidemic and a leading cause of blindness in working-age people around the world. Diabetic retinopathy (DR) and diabetic macular edema (DME) are common causes of visual impairment in people with diabetes and often indicate the presence of diabetes-associated preclinical micro- and macrovascular complications. As such, patients with DR and DME often display complex, highly comorbid profiles. Several treatments are currently available for the treatment of DME, including anti-vascular endothelial growth factor (VEGF) agents, which are administered via intravitreal injection. While the safety profiles of approved ocular anti-VEGF therapies have been reassuring, the high-risk nature of the DME patient population means that treatment must be carefully considered and a holistic approach to disease management should be taken. This requires multidisciplinary, collaborative care involving all relevant specialties to ensure that patients not only receive prompt treatment for DME but also appropriate consideration is taken of any systemic comorbidities to evaluate and minimize potentially serious safety issues.
Citation:
Considerations for management of patients with diabetic macular edema: optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaboration 2017 Diabetes Research and Clinical Practice
Publisher:
Elsevier
Journal:
Diabetes Research and Clinical Practice
Issue Date:
Jan-2017
URI:
http://hdl.handle.net/11287/620216
DOI:
10.1016/j.diabres.2017.01.013
Additional Links:
http://linkinghub.elsevier.com/retrieve/pii/S0168822716315248
Note:
This article is freely available via Open Access. Click on the Additional Link above to access the full-text via the publisher's site.
Type:
Journal Article
Language:
en
ISSN:
01688227
Appears in Collections:
Healthcare for Older People; 2017 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorStrain, Daviden
dc.contributor.authorCos, X.en
dc.contributor.authorPrünte, C.en
dc.date.accessioned2017-02-08T16:05:54Z-
dc.date.available2017-02-08T16:05:54Z-
dc.date.issued2017-01-
dc.identifier.citationConsiderations for management of patients with diabetic macular edema: optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaboration 2017 Diabetes Research and Clinical Practiceen
dc.identifier.issn01688227-
dc.identifier.doi10.1016/j.diabres.2017.01.013-
dc.identifier.urihttp://hdl.handle.net/11287/620216-
dc.description.abstractDiabetes is a growing worldwide epidemic and a leading cause of blindness in working-age people around the world. Diabetic retinopathy (DR) and diabetic macular edema (DME) are common causes of visual impairment in people with diabetes and often indicate the presence of diabetes-associated preclinical micro- and macrovascular complications. As such, patients with DR and DME often display complex, highly comorbid profiles. Several treatments are currently available for the treatment of DME, including anti-vascular endothelial growth factor (VEGF) agents, which are administered via intravitreal injection. While the safety profiles of approved ocular anti-VEGF therapies have been reassuring, the high-risk nature of the DME patient population means that treatment must be carefully considered and a holistic approach to disease management should be taken. This requires multidisciplinary, collaborative care involving all relevant specialties to ensure that patients not only receive prompt treatment for DME but also appropriate consideration is taken of any systemic comorbidities to evaluate and minimize potentially serious safety issues.en
dc.language.isoenen
dc.publisherElsevieren
dc.relation.urlhttp://linkinghub.elsevier.com/retrieve/pii/S0168822716315248en
dc.rightsArchived with thanks to Diabetes Research and Clinical Practiceen
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen
dc.subjectWessex Classification Subject Headings::Eldery care.en
dc.titleConsiderations for management of patients with diabetic macular edema: optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaborationen
dc.typeJournal Articleen
dc.identifier.journalDiabetes Research and Clinical Practiceen
dc.description.noteThis article is freely available via Open Access. Click on the Additional Link above to access the full-text via the publisher's site.en
dc.type.versionIn press (epub ahead of print)en
All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.